XML 74 R56.htm IDEA: XBRL DOCUMENT v3.20.1
Acquisitions - Additional Information (Detail)
€ in Millions
12 Months Ended
Sep. 30, 2019
shares
Oct. 31, 2018
USD ($)
shares
Oct. 31, 2018
USD ($)
Dec. 30, 2016
shares
Dec. 30, 2016
EUR (€)
Sep. 21, 2015
USD ($)
shares
Sep. 21, 2015
EUR (€)
shares
Sep. 21, 2015
EUR (€)
Dec. 31, 2019
USD ($)
Dec. 31, 2019
EUR (€)
Dec. 31, 2018
USD ($)
Dec. 31, 2019
EUR (€)
Oct. 15, 2019
USD ($)
Business Acquisition [Line Items]                          
Additional consideration                 $ 1,084,000   $ 10,637,000    
Revenue                 8,531,000   24,102,000    
Net loss                 $ (154,201,000)   (61,777,000)    
Escrow and security interest period               24 months          
Medical Surgery Technologies Ltd.                          
Business Acquisition [Line Items]                          
Cash consideration     $ 5,800,000                    
Stock consideration     $ 8,300,000                    
Unrestricted securities consideration                 75.00% 75.00%      
Revenue                 $ 0        
Net loss                 400,000        
Medical Surgery Technologies Ltd. | Ending on Twelve Month Anniversary | Maximum                          
Business Acquisition [Line Items]                          
Percentage of securities consideration     25.00%                    
Medical Surgery Technologies Ltd. | First Tranche                          
Business Acquisition [Line Items]                          
Cash consideration     $ 5,800,000                    
Common shares issued | shares   242,310                      
Medical Surgery Technologies Ltd. | Second Tranche                          
Business Acquisition [Line Items]                          
Common shares issued | shares 370,423                        
Additional consideration     $ 6,600,000                    
Stock consideration   $ 6,600,000                      
Senhance Surgical Robotic System Acquisition                          
Business Acquisition [Line Items]                          
Common shares issued | shares           1,195,647 1,195,647            
Additional consideration                 10,600,000        
Senhance Surgical Robotic System Acquisition | U.S. Dollars                          
Business Acquisition [Line Items]                          
Cash consideration           $ 25,000,000.0              
Senhance Surgical Robotic System Acquisition | Euro                          
Business Acquisition [Line Items]                          
Cash consideration | €             € 27.5            
Senhance Surgical Robotic System Acquisition | Second Tranche                          
Business Acquisition [Line Items]                          
Cash consideration | €                   € 15.1      
Common shares issued | shares       286,360                  
Additional consideration | €         € 5.0                
Aggregate fair market value | €             5.0            
Senhance Surgical Robotic System Acquisition | Second Tranche | U.S. Dollars                          
Business Acquisition [Line Items]                          
Cash consideration payable                 25,000,000.0        
Senhance Surgical Robotic System Acquisition | Second Tranche | Euro                          
Business Acquisition [Line Items]                          
Cash consideration payable | €                       € 22.5  
Senhance Surgical Robotic System Acquisition | Third Tranche                          
Business Acquisition [Line Items]                          
Cash consideration payable | €             15.0 € 15.0          
Senhance Surgical Robotic System Acquisition | Third Tranche | Minimum                          
Business Acquisition [Line Items]                          
Target revenue to be achieved | €             25.0 25.0          
Senhance Surgical Robotic System Acquisition | Fourth Tranche                          
Business Acquisition [Line Items]                          
Cash consideration | €                   € 2.4      
Cash consideration payable | €             € 2.5 € 2.5          
AutoLap                          
Business Acquisition [Line Items]                          
Disposal group, including discontinued operation, consideration                         $ 17,000,000.0
Proceeds from sale of productive assets                 16,000,000        
Consideration receivable                         $ 1,000,000.0
AutoLap                          
Business Acquisition [Line Items]                          
Gain from sale of assets, net                 $ (15,965,000)   $ 0